IP Director, European Patent Attorney
Rhiannon is a member of our life sciences patent team, working predominantly in the biotechnology, protein engineering, antibody technology and diagnostics sectors.
Her technical expertise encompasses:
Rhiannon has experience in prosecuting applications in the UK, at the EPO and in global portfolios. She also works on offensive and defensive oppositions, and appeals before the EPO.
Much of Rhiannon’s work is focussed on the prosecution, defence and opposition of patents at the EPO, particularly in the fields of antibody technology and protein engineering, in therapeutic and non-therapeutic fields, and in diagnostics. This work includes cases relating to therapeutics, from early leads to those on the market, and to further developments of marketed therapeutics.
Specifically in the field of diagnostics, Rhiannon works with clients on cases relating to the testing of individual patients for diagnosis and monitoring, to inform treatment decisions and allow for personalised therapy, as well as cases relating to specifically to the agents developed for use in diagnostic testing.
Rhiannon has a degree in Natural Sciences from the University of Cambridge, specializing in Virology and Immunology. Her final year project involved investigation of the primary and secondary mRNA structures involved in translational recoding in a murine endogenous retrovirus.
She joined Mewburn Ellis LLP in 2011, qualifying as a Chartered Patent Attorney in 2014 and a European Patent Attorney in 2015. Rhiannon became a Patent Director in 2019.